Identification of the physiological significance of an NRMGS using clinical correlation analysis with TCGA LUAD data could lead to the discovery of biomarkers in NRF2-overexpressing NSCLC patients. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.